BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Lone Star Bio

  New Cell & Gene Therapy Solutions From Form Bio Analyze Billions of Potential Construct Candidates, Reducing Time-to-Clinic

  Form Bio, the provider of advanced computational life sciences technology, announced today capabilities for cell and gene therapy companies to rapidly model billions of potential construct candidates.

  September 14, 2023

   · 

  6 min read
• Business

  JenaValve Appoints Shlomi Nachman to Board of Directors

  JenaValve Technology, Inc. announced that it has appointed Shlomi Nachman, experienced cardiovascular industry executive, to its Board of Directors.

  September 14, 2023

   · 

  3 min read
• Genetown

  NeuroSense to Participate in Upcoming ALS Conferences: PACTALS in Malaysia and NEALS in the U.S.

  NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, announced today it will participate in the following ALS conferences.

  September 14, 2023

   · 

  3 min read
• Drug Development

  Kiora Pharmaceuticals to Present Topline Results from the ABACUS Study at American Academy Ophthalmology (AAO); Phase 1b Study Evaluating KIO-301 in Retinitis Pigmentosa

  Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) announced that results from the ABACUS study of KIO-301 in patients with late-stage

  September 14, 2023

   · 

  4 min read
• Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical Center

  Alpha Tau Medical Ltd. announced that a patient with advanced inoperable pancreatic cancer has been treated in a clinical trial at Hadassah Medical Center in Jerusalem, Israel.

  September 14, 2023

   · 

  5 min read
• Phoenix PharmaLabs’ Lead Compound, PPL-138, Offers Promise as PTSD/AUD Treatment

  Phoenix PharmaLabs, Inc. today announced that in vivo studies demonstrated that the company’s lead compound, PPL-138, reduced symptoms of PTSD and decreased alcohol consumption in a rat model of PTSD/AUD (alcohol abuse disorder).

  September 14, 2023

   · 

  4 min read
• Business

  Virginia Oncology Associates Chooses the Ivenix Infusion System from Fresenius Kabi

  Fresenius Kabi announced today it has signed an agreement with Virginia Oncology Associates (VOA) under which VOA will purchase the Ivenix Infusion System to deliver medications for its patients.

  September 14, 2023

   · 

  3 min read
• Deals

  OKYO Pharma Limited Announces Withdrawal of Public Offering

  OKYO Pharma Limited today announced the withdrawal of its proposed public offering of ordinary shares and its termination of Freedom Capital Markets as underwriter.

  September 14, 2023

   · 

  2 min read
• Biotech Bay

  Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry

  Seeking to expand the knowledge base surrounding spectral flow cytometry, Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, has launched a global roadshow called Cytek Reveal.

  September 14, 2023

   · 

  8 min read
• Pharm Country

  ProofPilot and Legacy Health Strategies Partner to Scale Patient Engagement Strategies Beyond the Trial

  ProofPilot, a leading provider of innovative clinical trial automation, and Legacy Health Strategies, a seasoned strategic patient engagement consultancy, have joined forces to enhance their respective services.

  September 14, 2023

   · 

  2 min read